1976-05-01

QA762643, Passport

Daniel Maurice Louie and Kevin Gim Louie, a father-son pair, are both Canadian nationals who buy and sell significant quantities of chemicals used to manufacture synthetic cannabinoids (commonly known as “synthetic marijuana”) and synthetic cathinones (or stimulants, such as “bath salts”) which are generally classified as Schedule I controlled substances in the United States. Two other individuals and four foreign-based entities were also designated today under the Kingpin Act. For the past five years, Daniel and Kevin Louie have sold and shipped various U.S.-banned synthetic cannabinoids and cathinones to customers and vendors, domestically and internationally, primarily through their company, Source1herbs. Daniel and Kevin Louie have become a major source of supply for the synthetic drug industry, generating tens of millions of dollars in yearly sales. As new substances are banned in the United States, Daniel and Kevin Louie continually find replacements for banned synthetic chemicals in the United States, often mislabeling or advertising new chemicals as “not for human consumption.”

https://home.treasury.gov/news/press-releases/jl2585

2014-05-07

US

Foreign Narcotics Kingpin Sanctions Regulations, 31 C.F.R. part 598

OFAC-horizontal

Drugs

Blocking Property

The Foreign Narcotics Kingpin Sanctions Regulations, 31 CFR part 598 (FNKSR), implement the Foreign Narcotics Kingpin Designation Act (21 U.S.C. 1901–1908), which provides authority for the application of sanctions to significant foreign narcotics traffickers and their organizations operating worldwide.

SDN